4 hasil
CROSS REFERENCE TO RELATED APPLICATIONS
This application is a national phase filing under 35 U.S.C. .sctn. 371 of International application number PCT/IB2016/054641, filed Aug. 2, 2016, which claims priority from EP application number 15179448.4 filed Aug. 3, 2015. The International Application
The present invention concerns indolone-acetamide derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
European Patent No. 0 162 036 B1 discloses the compound (S)-.alpha.-ethyl-2-oxo-1-pyrrolidine acetamide, which is known under the
The present invention concerns indolone-acetamide derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
European Patent No. 0 162 036 B1 discloses the compound (S)-.alpha.-ethyl-2-oxo-1-pyrrolidine acetamide, which is known under the
BACKGROUND OF THE INVENTION
Adenosine modulates a wide range of physiological functions by interacting with specific cell surface receptors. The potential of adenosine receptors as drug targets was first reviewed in 1982. Adenosine is related both structurally and metabolically to the bioactive